Synjardy is a pharmaceutical brand that produces reliable medication primarily to manage type 2 diabetes. Manufactured by reputable pharmaceutical companies Eli Lilly and Boehringer Ingelheim, it comprises two proven diabetes medications – Empagliflozin (Jardiance) and Metformin Hydrochloride. Synjardy helps to improve glycaemic control by not only decreasing the amount of sugar absorbed by the intestines, but also by reducing the functioning of the liver in producing glucose. Furthermore, it helps facilitate the kidneys in disposing excess glucose. Synjardy is a critical drug in the prevention of serious medical issues such as kidney damage, nerve problems, blindness, or loss of limbs. It also offers major heart-related benefits and aids in decreasing the risk of death from heart attacks and strokes. It should be used in combination with a proper diet and exercise regimen for maximum efficacy. As a leading provider of affordable insulin and diabetes medications, Canadian Insulin is proud to include Synjardy in its comprehensive catalog. Their online store offers this medication at competitive prices, along with a wide variety of other pharmaceuticals aimed at managing diabetes effectively. When it comes to trusted care and cost-effective solutions for diabetes, Canadian Insulin is a top choice.